The metabolic phenotype of patients with primary aldosteronism: impact of subtype and sex – a multicenter-study of 3566 Caucasian and Asian subjects. Issue 3 (21st July 2022)
- Record Type:
- Journal Article
- Title:
- The metabolic phenotype of patients with primary aldosteronism: impact of subtype and sex – a multicenter-study of 3566 Caucasian and Asian subjects. Issue 3 (21st July 2022)
- Main Title:
- The metabolic phenotype of patients with primary aldosteronism: impact of subtype and sex – a multicenter-study of 3566 Caucasian and Asian subjects
- Authors:
- Spyroglou, Ariadni
Handgriff, Laura
Müller, Lisa
Schwarzlmüller, Paul
Parasiliti-Caprino, Mirko
Fuss, Carmina Teresa
Remde, Hana
Hirsch, Anna
O'Toole, Samuel Matthew
Thuzar, Moe
Petramala, Luigi
Letizia, Claudio
Deflorenne, Elisa
Amar, Laurence
Vrckovnik, Rok
Kocjan, Tomaz
Zhang, Catherine D
Li, Dingfeng
Singh, Sumitabh
Katabami, Takuyuki
Yoneda, Takashi
Murakami, Masanori
Wada, Norio
Inagaki, Nobuya
Quinkler, Marcus
Ghigo, Ezio
Maccario, Mauro
Stowasser, Michael
Drake, William M
Fassnacht, Martin
Bancos, Irina
Reincke, Martin
Naruse, Mitsuhide
Beuschlein, Felix
… (more) - Abstract:
- Abstract : Background: Accumulating evidence suggests that primary aldosteronism (PA) is associated with several features of the metabolic syndrome, in particular with obesity, type 2 diabetes mellitus, and dyslipidemia. Whether these manifestations are primarily linked to aldosterone-producing adenoma (APA) or bilateral idiopathic hyperaldosteronism (IHA) remains unclear. The aim of the present study was to investigate differences in metabolic parameters between APA and IHA patients and to assess the impact of treatment on these clinical characteristics. Methods: We conducted a retrospective multicenter study including 3566 patients with APA or IHA of Caucasian and Asian origin. We compared the prevalence of metabolic disorders between APA and IHA patients at the time of diagnosis and 1-year post-intervention, with special references to sex differences. Furthermore, correlations between metabolic parameters and plasma aldosterone, renin, or plasma cortisol levels after 1 mg dexamethasone (DST) were performed. Results: As expected, APA patients were characterized by higher plasma aldosterone and lower serum potassium levels. Only female IHA patients demonstrated significantly worse metabolic parameters than age-matched female APA patients, which were associated with lower cortisol levels upon DST. One-year post-intervention, female adrenalectomized patients showed deterioration of their lipid profile, when compared to patients treated with mineralocorticoid receptorAbstract : Background: Accumulating evidence suggests that primary aldosteronism (PA) is associated with several features of the metabolic syndrome, in particular with obesity, type 2 diabetes mellitus, and dyslipidemia. Whether these manifestations are primarily linked to aldosterone-producing adenoma (APA) or bilateral idiopathic hyperaldosteronism (IHA) remains unclear. The aim of the present study was to investigate differences in metabolic parameters between APA and IHA patients and to assess the impact of treatment on these clinical characteristics. Methods: We conducted a retrospective multicenter study including 3566 patients with APA or IHA of Caucasian and Asian origin. We compared the prevalence of metabolic disorders between APA and IHA patients at the time of diagnosis and 1-year post-intervention, with special references to sex differences. Furthermore, correlations between metabolic parameters and plasma aldosterone, renin, or plasma cortisol levels after 1 mg dexamethasone (DST) were performed. Results: As expected, APA patients were characterized by higher plasma aldosterone and lower serum potassium levels. Only female IHA patients demonstrated significantly worse metabolic parameters than age-matched female APA patients, which were associated with lower cortisol levels upon DST. One-year post-intervention, female adrenalectomized patients showed deterioration of their lipid profile, when compared to patients treated with mineralocorticoid receptor antagonists. Plasma aldosterone levels negatively correlated with the BMI only in APA patients. Conclusions: Metabolic alterations appear more prominent in women with IHA. Although IHA patients have worse metabolic profiles, a correlation with cortisol autonomy is documented only in APAs, suggesting an uncoupling of cortisol action from metabolic traits in IHA patients. … (more)
- Is Part Of:
- European journal of endocrinology. Volume 187:Issue 3(2022)
- Journal:
- European journal of endocrinology
- Issue:
- Volume 187:Issue 3(2022)
- Issue Display:
- Volume 187, Issue 3 (2022)
- Year:
- 2022
- Volume:
- 187
- Issue:
- 3
- Issue Sort Value:
- 2022-0187-0003-0000
- Page Start:
- 361
- Page End:
- 372
- Publication Date:
- 2022-07-21
- Subjects:
- Endocrinology -- Periodicals
616.4005 - Journal URLs:
- http://www.bioscientifica.com/ ↗
http://www.eje-online.org/ ↗
https://academic.oup.com/ejendo ↗ - DOI:
- 10.1530/EJE-22-0040 ↗
- Languages:
- English
- ISSNs:
- 0804-4643
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 25683.xml